Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MIR137 host gene | 0.839 | 0.038 |
|
disease | 0.460 | None | 0.500 | 6 | 2 | 2011 | 2019 | |||||||||
|
clathrin interactor 1 | 0.931 | 0.038 | 0.54 |
|
disease | 0.060 | None | 0.833 | 6 | 1 | 2005 | 2008 | ||||||||
|
leucine rich repeat transmembrane neuronal 1 | 0.931 | 0.038 | 0.59 |
|
disease | 0.540 | None | 1.000 | 4 | 0 | 2007 | 2014 | ||||||||
|
schizophrenia 13 | 0.931 | 0.038 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2008 | |||||||||
|
ADNP homeobox 2 | 1.000 | 0.038 | 0.70 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
G protein-coupled receptor 85 | 1.000 | 0.038 | 0.77 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2008 | 2013 | ||||||||
|
calcium voltage-gated channel auxiliary subunit gamma 8 | 1.000 | 0.038 | 0.96 |
|
disease | 0.320 | None | 1.000 | 2 | 2 | 2013 | 2016 | ||||||||
|
schizophrenia disorder 2 | 1.000 | 0.038 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2018 | |||||||||
|
Rho GTPase activating protein 11B | 0.931 | 0.038 | 2.6E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2019 | ||||||||
|
N-acetylated alpha-linked acidic dipeptidase 2 | 1.000 | 0.038 | 1.4E-20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
zinc finger protein 729 | 1.000 | 0.038 | 0.40 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Rho GTPase activating protein 33 | 1.000 | 0.038 | 2.9E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
catechol-O-methyltransferase domain containing 1 | 1.000 | 0.038 | 3.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
clavesin 2 | 1.000 | 0.038 | 1.4E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
golgin A8 family member A | 0.931 | 0.038 | 3.9E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
F-box and leucine rich repeat protein 21, pseudogene | 1.000 | 0.038 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
adaptor related protein complex 3 subunit mu 1 | 1.000 | 0.038 | 2.7E-02 |
|
disease | 0.310 | None | < 0.001 | 1 | 1 | 2009 | 2009 | ||||||||
|
NADPH dependent diflavin oxidoreductase 1 | 1.000 | 0.038 | 4.8E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
T cell receptor beta variable 7-2 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
immunoglobulin lambda variable 3-25 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ATPase 13A5 | 1.000 | 0.038 | 2.4E-49 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
Phobia, specific | 0.821 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
NADH:ubiquinone oxidoreductase core subunit V2 pseudogene 1 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MINDY lysine 48 deubiquitinase 2 | 0.931 | 0.038 | 1.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
schizophrenia disorder 1 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 |